Haddon Heights, New Jersey Clinical Trials

A listing of Haddon Heights, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 84 clinical trials
Wells and Enteric Disease Transmission Trial (WET - Trial)

Approximately 40 million people in the US are served by private wells, many of which are untreated. The investigators estimate that 1.29 million cases of gastrointestinal illness (GI) per year are attributed to consuming water from untreated private wells in the US. These cases of GI can cause a significant …

Temple University
 (8.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase 2 Trial of CD19 Redirected Autologous T Cells

This is an open-label, four-cohort, phase 2 study to determine the efficacy of CART19 in pediatric and young adult patientswith hypodiploid (Cohort A) or t(17;19) B-ALL (Cohort B), infants with very high risk KMT2A B-ALL (Cohort C), and in patients with central nervous system (CNS) relapse who did not receive …

Children's Hospital of Philadelphia
 (8.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

hodgkin's disease
cns tumor
HRAS
pleural effusion
anti-cancer agents
Children's Hospital of Philadelphia
 (8.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
API Trial-T2

API Trial-T12

Test AP Sit1
 (8.7 away) Contact site
  • 0 views
  • 18 Sep, 2024
  • 1 location
PCSK9i in AAA1236

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (8.7 away) Contact site
  • 0 views
  • 04 Mar, 2025
  • +1 other locations
PCSK9i in AAA1237

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (8.7 away) Contact site
  • 0 views
  • 07 May, 2025
  • +1 other locations
PCSK9i in AAA1240

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (8.7 away) Contact site
  • 0 views
  • 09 May, 2025
  • +1 other locations
PCSK9i in AAA1241

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (8.7 away) Contact site
  • 0 views
  • 13 May, 2025
  • +1 other locations
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

This is a phase 1/2 multicenter, multi-regional, open-label, first-in-human study of IBI3014 in participants with unresectable locally advanced or metastatic solid tumors.

Hospital Test1a
 (8.7 away) Contact site
  • 0 views
  • 22 Aug, 2025
  • +1 other locations
Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

SARS
respiratory distress
acute respiratory distress
covid-19
acute respiratory syndrome (sars)
Thomas Jefferson University
 (7.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations